Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Iruplinalkib is an inhibitor of anaplastic lymphoma kinase (ALK), ALKL1196M, and ALKC1156Y (IC50s = 1.6, 1.7, and 1.8 nM, respectively).1 It inhibits the proliferation of Ba/F3 cells expressing wild-type ALK, ALKL1196M, ALKC1156Y, or a variety of ALK fusion proteins (IC50s = 13, 24, 21, and 1-96 nM, respectively) and Karpas 299 anaplastic large-cell lymphoma (ALCL) cells (IC50 = 14.5 nM). Iruplinalkib also inhibits the proliferation of Ba/F3 cells expressing wild-type c-Ros oncogene 1 (ROS1) or ROS1 fusion proteins (IC50s = 11 and 12-22 nM, respectively). It reduces tumor growth in a crizotinib-resistant patient-derived xenograft (PDX) mouse model of non-small cell lung cancer (NSCLC) at 2.5-10 mg/kg.
WARNING This product is not for human or veterinary use.
1. Discovery and preclinical evaluations of WX-